Integrating complex genomic datasets and tumour cell sensitivity profiles to address a 'simple' question: which patients should get this drug?
BMC Medicine 2009, 7:78 doi:10.1186/1741-7015-7-78
Pre-publication versions of this article and reviewers' reports
|Resubmission - Version 2||24 Nov 2009|
|Editorial acceptance||24 Nov 2009|
|Published||14 Dec 2009|
Due to technical difficulties, the pre-publication history may be incomplete. If you require any further information please contact the journal.